Fetal growth and childhood cholesterol levels in the United States

Cynthia L Ogden1, Kenneth C Schoendorf, John L Kiely

  • 1National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA. cogden@cdc.gov

Insights

Infants born small-for-gestational age (SGA) may have a higher risk of elevated cholesterol in early childhood. This study found a potential association, though not statistically significant, between reduced fetal growth and cholesterol levels.

Area of Science:

  • Pediatrics
  • Public Health
  • Endocrinology

Background:

  • Fetal development significantly influences long-term health outcomes.
  • Small-for-gestational age (SGA) birth is a marker of altered fetal growth.
  • Early childhood cholesterol levels are critical indicators of future cardiovascular health.

Purpose of the Study:

  • To investigate the association between being born small-for-gestational age (SGA) and the risk of high cholesterol in early childhood.
  • To determine if reduced fetal growth predicts elevated serum total cholesterol levels in children aged 4-6 years.

Main Methods:

  • Analysis of data from 1727 children (ages 4-6) from the third US National Health and Nutrition Examination Survey.
  • Utilized birth certificate data and blood cholesterol measurements.
  • Employed logistic regression to assess odds of high cholesterol in SGA vs. non-SGA children, controlling for covariates.

Main Results:

  • Approximately 11% of children were born SGA.
  • SGA children showed a non-significant trend towards higher odds of elevated cholesterol (OR 1.97).
  • Gestation-adjusted birthweight showed a non-significant inverse relationship with cholesterol levels.

Conclusions:

  • A potential association exists between reduced fetal growth (SGA) and increased cholesterol in early childhood.
  • Further research is needed to confirm the statistical significance and clinical implications of this finding.
  • Early life growth patterns may impact lipid metabolism and cardiovascular risk later in life.

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...